How Much Blood Loss Is Too Much for a 1-Level Open Lumbar Fusion?

Background Despite the known association between increased estimated blood loss (EBL) and suboptimal perioperative outcomes, the exact threshold of EBL that impacts outcomes following elective spine surgery remains unknown. In a cohort of patients undergoing elective 1-level open posterior lumbar fusion, we sought to identify EBL thresholds associated with: (1) prolonged length of stay (LOS), (2) postoperative complications, and (3) patient-reported outcomes (PROs). Methods A retrospective, single-center study was performed of patients undergoing elective, 1-level open posterior lumbar fusion with and without interbody fusion between October 2010 and April 2021. The primary exposure variable was EBL. Primary outcomes included: (1) LOS, (2) 30-day complications, and (3) 3-month PROs. Minimum clinically important difference was set at 30% improvement from baseline. For purposes of receiver-operating characteristic curves, LOS was dichotomized as 1 vs ≥2 days. Results Of the 2028 patients undergoing posterior lumbar fusion surgery, 1183 underwent 1-level fusions, 763 (64.5%) with interbody fusion and 420 (35.5%) without. With interbody fusion: Median (interquartile range [IQR]) EBL was 350 mL (200–600), and median (IQR) LOS was 2 days (2–3). A positive linear association was found between EBL and LOS (P < 0.001) but not with PROs. EBL above 275 mL was associated with LOS beyond postoperative day 1 (POD1) (area under the curve [AUC] = 0.73, 95% CI 0.68–0.78, P < 0.001), with no significant association with overall complications or PROs. Without interbody fusion: Median EBL (IQR) was 300 mL (150–500), and median (IQR) LOS was 3 days (2–4). A positive linear association was found between EBL and LOS (P < 0.001) but not with PROs. EBL above 238 mL was associated with LOS beyond POD1 (AUC = 0.78, 95% CI 0.71–0.85, P < 0.001), with no impact on overall complications or PROs. Conclusions In patients undergoing 1-level posterior lumbar fusion, EBL volumes greater than 275 and 238 mL in patients with and without interbody fusion, respectively, were associated with increased LOS beyond POD1. No effect was found regarding 30-day complications and 3-month PROs. Although EBL did not directly impact complications or PROs, surgeons may expect longer LOS when higher EBL is reported. Clinical Relevance EBL above 275 mL with an interbody and 238 mL without an interbody were associated with prolonged LOS beyond POD1 in 1-level open lumbar fusion. Level of Evidence 3.

[1]  Y. R. Rampersaud,et al.  Lumbar Fusion Surgery for Patients With Back Pain and Degenerative Disc Disease: An Observational Study From the Canadian Spine Outcomes and Research Network , 2021, Global spine journal.

[2]  Kristin R. Archer,et al.  A Novel Lumbar Total Joint Replacement May be an Improvement Over Fusion for Degenerative Lumbar Conditions: A Comparative Analysis of Patient-Reported Outcomes at One Year. , 2020, The spine journal : official journal of the North American Spine Society.

[3]  Xinggui Tian,et al.  Total and hidden blood loss between open posterior lumbar interbody fusion and transforaminal lumbar interbody fusion by Wiltse approach , 2020, Medicine.

[4]  A. Sill,et al.  Measured versus Estimated Blood Loss: Interim Analysis of a Prospective Quality Improvement Study , 2020, The American surgeon.

[5]  Kristin R. Archer,et al.  Measuring Clinically Relevant Improvement After Lumbar Spine Surgery: Is It Time for Something New? , 2020, The spine journal : official journal of the North American Spine Society.

[6]  Sohail K. Mirza,et al.  Trends in Lumbar Fusion Procedure Rates and Associated Hospital Costs for Degenerative Spinal Diseases in the United States, 2004 to 2015 , 2019, Spine.

[7]  Amit Jain,et al.  Multilevel Arthrodesis for Adult Spinal Deformity: When Should We Anticipate Major Blood Loss? , 2019, Spine deformity.

[8]  Carl B Paulino,et al.  Costs and complications of increased length of stay following adolescent idiopathic scoliosis surgery , 2019, Journal of pediatric orthopedics. Part B.

[9]  C. Moore,et al.  Blood Loss Trends and Financial Implications in Adolescent Idiopathic Scoliosis , 2018, Clinical spine surgery.

[10]  R. Shinjo,et al.  Predictors of Prolonged Length of Stay After Lumbar Interbody Fusion: A Multicenter Study , 2018, Global spine journal.

[11]  J. Bible,et al.  Blood-loss Management in Spine Surgery. , 2018, The Journal of the American Academy of Orthopaedic Surgeons.

[12]  G. Sutherland,et al.  Lumbar Fusion for Degenerative Disease: A Systematic Review and Meta‐Analysis , 2017, Neurosurgery.

[13]  J. Vital,et al.  One-Level Lumbar Degenerative Spondylolisthesis and Posterior Approach: Is Transforaminal Lateral Interbody Fusion Mandatory? A Randomized Controlled Trial With 2-Year Follow-Up , 2017, Spine.

[14]  H. Yasunaga,et al.  Risk of infectious complications associated with blood transfusion in elective spinal surgery-a propensity score matched analysis. , 2015, The spine journal : official journal of the North American Spine Society.

[15]  Yu-hua Huang,et al.  Significant Blood Loss in Lumbar Fusion Surgery for Degenerative Spine. , 2015, World neurosurgery.

[16]  R. Weil,et al.  The effect of blood transfusion on short-term, perioperative outcomes in elective spine surgery , 2014, Journal of Clinical Neuroscience.

[17]  John D. Koerner,et al.  Blood Loss During Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis , 2014, Spine.

[18]  J. Woodward,et al.  In vitro transfusion of red blood cells results in decreased cytokine production by human T cells , 2014, The journal of trauma and acute care surgery.

[19]  F. Harrell,et al.  Do Optimal Prognostic Thresholds in Continuous Physiological Variables Really Exist? Analysis of Origin of Apparent Thresholds, with Systematic Review for Peak Oxygen Consumption, Ejection Fraction and BNP , 2014, PloS one.

[20]  Bedda L. Rosario,et al.  The association between perioperative allogeneic transfusion volume and postoperative infection in patients following lumbar spine surgery. , 2013, The Journal of bone and joint surgery. American volume.

[21]  Y. Ou,et al.  Clinical Outcomes of Discectomy in Octogenarian Patients With Lumbar Disc Herniation , 2013, Journal of spinal disorders & techniques.

[22]  J. A. Hoskins,et al.  Predictive Factors of Hospital Stay in Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion and Instrumentation , 2012, Spine.

[23]  James H. Stephen,et al.  Patient Comorbidities and Complications After Spinal Surgery: A Societal-Based Cost Analysis , 2012, Spine.

[24]  R. Deyo,et al.  Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. , 2010, JAMA.

[25]  J. Buchowski,et al.  Effect of Fibrin Sealant on Drain Output and Duration of Hospitalization After Multilevel Anterior Cervical Fusion: A Retrospective Matched Pair Analysis , 2008, Spine.

[26]  D. Polly,et al.  Perioperative blood and blood product management for spinal deformity surgery. , 2003, The spine journal : official journal of the North American Spine Society.

[27]  R. Davenport,et al.  Transfusion‐related acute lung injury: femme fatale? , 2001, Transfusion.

[28]  M. Kollef,et al.  Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  P. Romano,et al.  Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism. , 1998, Archives of internal medicine.

[30]  P. Lipsett,et al.  Does intraoperative blood loss affect antibiotic serum and tissue concentrations? , 1996, Archives of surgery.

[31]  L. S. Rosenfeld,et al.  Reasons for prolonged hospital stay; a study of need for hospital care. , 1957, Journal of chronic diseases.